ArticlePacing and clinical electrophysiology : PACE2026
Dual-Chamber Leadless Pacemaker Implants in the Young.
Article in Pacing and clinical electrophysiology : PACE, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionYoung populations with traditional dual-chamber pacemakers are prone to re-intervention compared to their adult populations due to their active lifestyle. AVEIR DR Dual-Chamber Leadless Pacemakers are a new and less invasive approach to traditional pacemakers. Currently, few reports exist to support dual-chamber leadless pacemaker implants in the young.
methodsAVEIR DR dual-chamber leadless pacemakers were implanted in young patients (< 21 years old), at UC Davis Medical Center. Internal jugular vein was the preferred approach for most patients during implantation; however, one patient had a femoral approach after lead extraction.
resultsFive patients received the AVEIR DR dual-chamber leadless pacemaker with a median age of 15 years, and a median weight of 65.8 kg. Access from the internal jugular vein was used in four out of five patients. Median predicted atrial longevity and ventricular longevity were 11.8 and 14.6 years, respectively. Atrial and ventricular impedance, threshold, and pacing were monitored with no complications with a median follow-up of 13 months.
conclusionDual-chamber leadless pacemaker implants are feasible in young patients through femoral and internal jugular vein access.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.